Over 7000 Participants Join Seoul’s Free Youth Tour Guide Program YGG – Foreign Visitor Bookings Expand
OQP BioM Shareholder Alliance: Quest-pharma Tech’s Takeover Bid for OQP BioM Meets Scrutiny Amid Accusations and Silence
MEDIPEAU Inc Showcases “BARRICURE” Medical Device Brand for Damaged Skin at Malaysia’s ‘Immunodermatology Updates 2025’ Symposium
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
Over 7000 Participants Join Seoul’s Free Youth Tour Guide Program YGG – Foreign Visitor Bookings Expand
OQP BioM Shareholder Alliance: Quest-pharma Tech’s Takeover Bid for OQP BioM Meets Scrutiny Amid Accusations and Silence
MEDIPEAU Inc Showcases “BARRICURE” Medical Device Brand for Damaged Skin at Malaysia’s ‘Immunodermatology Updates 2025’ Symposium
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
